Prize pHight: who says the natural products industry should decry drugs with OTC status? The opportunity for exploiting underappreciated weaknesses in ... An article from: Nutraceuticals World Buy on Amazon
Facebook LinkedIn

Prize pHight: who says the natural products industry should decry drugs with OTC status? The opportunity for exploiting underappreciated weaknesses in ... An article from: Nutraceuticals World

9.95 USD

Available for download now

Book Details
Author(s) Anthony Almada
Publisher Rodman Publishing
ISBN / ASIN B001JTZPQU
ISBN-13 978B001JTZPQ1
Availability Available for download now
Sales Rank #99,999,999
Marketplace United States 🇺🇸
Description
This digital document is an article from Nutraceuticals World, published by Rodman Publishing on March 1, 2008. The length of the article is 843 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Prize pHight: who says the natural products industry should decry drugs with OTC status? The opportunity for exploiting underappreciated weaknesses in the digestive health category, au naturel, is explosive.(PROPRIETARY PERSPECTIVES)
Author: Anthony Almada
Publication:Nutraceuticals World (Magazine/Journal)
Date: March 1, 2008
Publisher: Rodman Publishing
Volume: 11 Issue: 3 Page: 28(2)

Distributed by Gale, a part of Cengage Learning
Donate to EbookNetworking
No Prev
No Next